Tectonic Therapeutic Income Statement (2017-2026) | TECX

Income Statement Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating items
Research & Development (Quarter)
22.54M23.04M19.00M19.25M18.88M15.92M18.14M17.33M8.77M8.13M7.19M10.82M7.07M14.32M9.16M13.04M17.18M16.93M16.34M20.87M
Selling, General & Administrative (Quarter)
8.83M9.58M8.96M10.16M8.90M7.07M7.12M7.89M1.86M1.98M2.18M2.15M4.35M5.32M4.83M5.26M5.15M4.96M5.17M6.43M
Other Operating Expenses (Quarter)
83.74M
Operating Expenses (Quarter)
31.38M32.62M27.96M29.42M27.77M22.98M25.26M25.22M10.63M10.11M9.37M12.97M11.42M19.64M13.99M18.30M22.33M21.89M21.52M27.30M
Operating Income (Quarter)
-31.38M-32.62M-27.96M-29.42M-27.77M-22.98M-25.26M-25.22M-10.63M-10.11M-9.37M-12.97M-11.42M-19.64M-13.99M-18.30M-22.33M-21.89M-21.52M-27.30M
EBIT (Quarter)
-31.38M-32.62M-27.96M-29.42M-27.77M-22.98M-25.26M-25.22M-10.63M-10.11M-9.37M-12.97M-11.42M-19.64M-13.99M-18.30M-22.33M-21.89M-21.52M-27.30M
Non-operating items
Non Operating Investment Income (Quarter)
Interest & Investment Income (Quarter)
0.01M0.00M-0.24M-0.37M-0.28M0.11M0.24M0.25M0.22M0.10M0.13M0.26M0.32M1.95M1.74M2.44M3.39M2.90M2.56M2.18M
Other Non Operating Income (Quarter)
-0.02M0.01M-0.04M0.01M-0.10M0.01M-0.01M-0.00M0.41M-0.40M-0.01M-0.01M-0.10M-0.03M-0.05M-0.03M-0.01M-0.11M
Non Operating Income (Quarter)
-0.01M0.01M-0.27M-0.41M-0.28M0.02M0.22M0.26M-0.01M-0.00M0.41M-2.25M-1.25M1.92M1.16M2.39M3.32M-0.03M-0.27M2.06M
Net income details
EBT (Quarter)
-31.39M-32.62M-28.21M-29.83M-28.06M-22.87M-25.01M-24.97M-10.45M-10.05M-9.28M-12.74M-12.67M-17.72M-9.87M-15.87M-19.01M-19.04M54.18M-25.13M
Tax Provisions (Quarter)
0.98M0.25M
Profit After Tax (Quarter)
-31.39M-32.61M-28.23M-29.83M-28.05M-22.97M-25.03M-14.45M-10.46M-10.05M-7.85M-15.22M-12.67M-17.72M-12.39M-15.90M-19.98M-19.04M-19.25M-25.24M
Income from Continuing Operations (Quarter)
-31.39M-32.62M-28.21M-29.83M-28.06M-22.87M-25.01M-24.97M-10.45M-10.05M-9.28M-12.74M-12.67M-17.72M-9.87M-15.87M-19.98M-19.04M53.92M-25.13M
Consolidated Net Income (Quarter)
-31.39M-32.62M-28.21M-29.83M-28.06M-22.87M-25.01M-24.97M-10.45M-10.05M-9.28M-12.74M-12.67M-17.72M-9.87M-15.87M-19.98M-19.04M53.92M-25.13M
Income towards Parent Company (Quarter)
-31.39M-32.62M-28.21M-29.83M-28.06M-22.87M-25.01M-24.97M-10.45M-10.05M-9.28M-12.74M-12.67M-17.72M-9.87M-15.87M-19.98M-19.04M53.92M-25.13M
Preferred Dividend Payments (Quarter)
Net Income towards Common Stockholders (Quarter)
-31.39M-32.62M-28.21M-29.83M-28.05M-22.97M-25.03M-24.97M67.48M-10.05M-7.87M-15.22M-12.67M-17.72M-12.37M-15.91M-19.98M-19.04M-19.23M-25.24M
Additional items
EPS (Basic) (Quarter)
-0.74-0.75-0.65-0.68-0.64-0.52-0.57-0.57-8.51-7.62-5.70-10.97-4.34-1.200.33-0.93-1.07-1.02-1.03-1.34
EPS (Weighted Average and Diluted) (Quarter)
-0.74-0.75-0.65-0.68-0.64-0.52-0.57-0.57-8.51-7.62-5.70-10.97-4.34-1.200.33-0.93-1.07-1.02-1.03-1.34
Shares Outstanding (Weighted Average) (Quarter)
0.04M0.04M0.04M0.04M43.70M43.72M43.74M44.04M44.13M44.53M1.27M1.39M2.15M14.73M8.49M17.16M17.92M18.19M18.32M18.77M
Shares Outstanding (Diluted Average) (Quarter)
0.04M0.04M0.04M0.04M43.70M43.72M43.74M44.04M1.21M1.32M1.27M1.39M2.92M6.37M8.49M17.16M17.92M18.19M18.32M18.77M
EBITDA (Quarter)
-31.39M-32.61M-28.23M-29.83M-28.05M-22.98M-25.26M-25.22M-10.63M-10.11M-9.37M-12.97M-11.42M-19.64M-13.99M-18.30M-22.33M-21.89M-21.52M-27.30M
Interest Expenses (Quarter)
0.02M0.04M0.04M0.04M0.03M0.03M0.03M0.03M0.02M0.02M0.02M0.01M0.01M0.01M
Tax Rate (Quarter)
-5.13%0.47%